sb 203580 has been researched along with Hyperglycemia in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Guo, R; Huang, R; Li, S; Tian, L; Wu, K; Yan, H; You, Q | 1 |
| Allen, SR; Cawyer, CR; Horvat, D; Jones, RO; Kuehl, TJ; Leonard, D; Uddin, MN; Zawieja, DC | 1 |
| Beeram, MR; Kohl-Thomas, BM; Kuehl, TJ; Lin, S; Nguyen, T; Pantho, AF; Uddin, MN; Zawieja, DC | 1 |
| Afroze, SH; Allen, S; Cawyer, C; Drever, N; Jones, R; Kuehl, T; Uddin, MN; Zawieja, DC | 1 |
| Cao, L; Chen, X; Li, W; Ma, Q; Xiao, X | 1 |
| Kowluru, A; Sidarala, V | 1 |
| Botez, GM; Sima, AV; Simionescu, M; Stancu, CS; Toma, L | 1 |
| Hosomi, N; Imachi, H; Ishida, T; Iwama, H; Li, J; Masugata, H; Murao, K; Nishiuchi, T; Yu, X; Zhang, GX | 1 |
| Chen, JS; Chen, JW; Chen, YH; Huang, PH; Leu, HB; Lin, FY; Lin, SJ; Tsai, HY; Wu, TC | 1 |
| Huang, H; Huang, J; Huang, K; Lan, T; Liu, P; Liu, W; Peng, J; Shen, X; Xie, X | 1 |
| Gan, Y; Kuang, D; Ni, J; She, T; Wang, G; Wang, X; Yue, J; Zhao, X | 1 |
| Akasaka, T; Imanishi, T; Kobayashi, K; Kuki, S; Matsuo, Y; Obana, M | 1 |
| Igarashi, M; Ishii, H; Jiang, ZY; King, GL; Kuboki, K; Meier, M; Rhodes, CJ; Takahara, N; Wakasaki, H; Yamauchi, T | 1 |
| Arndt, H; Palitzsch, KD; Schäffler, A; Schölmerich, J | 1 |
| Brodbeck, K; Häring, HU; Pfeiffer, A; Sauer, U; Schleicher, ED; Weigert, C | 1 |
15 other study(ies) available for sb 203580 and Hyperglycemia
| Article | Year |
|---|---|
Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Butadienes; Cell Line; Cell Survival; Enzyme Inhibitors; Flavanones; Fruit; Glucose; Hyperglycemia; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Nitriles; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Plant Extracts; Pyridines; Rats; Reactive Oxygen Species | 2014 |
Hyperglycemia impairs cytotrophoblast function via stress signaling.
Topics: Antigens, CD; Diabetes, Gestational; Endoglin; Enzyme-Linked Immunosorbent Assay; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Interleukin-6; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Placenta Growth Factor; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; PPAR gamma; Pregnancy; Pregnancy Proteins; Pyridines; Receptors, Cell Surface; Rosiglitazone; Signal Transduction; Thiazolidinediones; Trophoblasts; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2014 |
Hyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells.
Topics: Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Down-Regulation; Female; Glucose; Guanylate Cyclase; Humans; Hyperglycemia; Imidazoles; Pregnancy; Pregnancy Trimester, First; Pyridines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Soluble Guanylyl Cyclase; Thiazolidinediones; Trophoblasts | 2015 |
Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 9; Cells, Cultured; Cyclooxygenase 2; Enzyme Inhibitors; Female; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Interleukin-6; p38 Mitogen-Activated Protein Kinases; Placenta Growth Factor; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rosiglitazone; Signal Transduction; Thiazolidinediones; Trophoblasts; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2016 |
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Movement; Diabetes Complications; Flavonoids; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hyperglycemia; Imidazoles; MAP Kinase Signaling System; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Pyridines; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Exposure to chronic hyperglycemic conditions results in Ras-related C3 botulinum toxin substrate 1 (Rac1)-mediated activation of p53 and ATM kinase in pancreatic β-cells.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Morpholines; p38 Mitogen-Activated Protein Kinases; Prenylation; Pyridines; Pyrones; Quinolines; rac1 GTP-Binding Protein; Rats; Simvastatin; Tumor Suppressor Protein p53 | 2017 |
Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose.
Topics: Cell Line; Cell Proliferation; Chemokine CCL2; Endothelium, Vascular; Gene Expression; Glucose; Glycation End Products, Advanced; Humans; Hyperglycemia; Imidazoles; Inflammation; Lipoproteins, LDL; NADPH Oxidase 4; NADPH Oxidases; Nitriles; Pyridines; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sulfones | 2009 |
Hyperglycemia suppresses ABCA1 expression in vascular smooth muscle cells.
Topics: ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cells, Cultured; Gene Expression Regulation; Glucose; Humans; Hyperglycemia; Imidazoles; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pyridines; Transcription, Genetic | 2010 |
Globular adiponectin improves high glucose-suppressed endothelial progenitor cell function through endothelial nitric oxide synthase dependent mechanisms.
Topics: Adiponectin; Animals; Cell Movement; Cells, Cultured; Cellular Senescence; Endothelial Cells; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Humans; Hyperglycemia; Imidazoles; Mice; Mice, Nude; Nitric Oxide; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Random Allocation; Stem Cells | 2011 |
S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition.
Topics: Animals; Diabetic Nephropathies; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Flavonoids; Glucose; Hyperglycemia; Imidazoles; Kidney; Lysophospholipids; MAP Kinase Signaling System; Mesangial Cells; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sphingosine; Sphingosine-1-Phosphate Receptors | 2012 |
Hyperglycemia suppresses cardiac stem cell homing to peri-infarcted myocardium via regulation of ERK1/2 and p38 MAPK activities.
Topics: Animals; Cell Movement; Cells, Cultured; Diabetes Mellitus, Experimental; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression; Hyperglycemia; Imidazoles; Male; MAP Kinase Signaling System; Myocardial Infarction; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Rats; Rats, Sprague-Dawley; Stem Cell Factor; Stem Cells; Ventricular Pressure | 2012 |
Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase.
Topics: Cell Differentiation; Cell Proliferation; Cells, Cultured; Cellular Senescence; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Glucose; Humans; Hyperglycemia; Imidazoles; Mitosis; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Stem Cells | 2006 |
Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways.
Topics: Adenoviridae; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Diabetes Mellitus, Experimental; Enzyme Activation; Glucose; Humans; Hyperglycemia; Imidazoles; Indoles; Isoenzymes; Male; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Osmolar Concentration; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein Kinase C beta; Pyridines; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1999 |
Amelioration of hyperglycemic and hyperosmotic induced vascular dysfunction by in vivo inhibition of protein kinase C and p38 MAP kinase pathway in the rat mesenteric microcirculation.
Topics: Animals; Capillaries; Cell Adhesion; Diabetic Angiopathies; Diuretics, Osmotic; Enzyme Inhibitors; Glucose; Hyperglycemia; Imidazoles; Leukocytes; Male; Mannitol; MAP Kinase Signaling System; Microcirculation; Mitogen-Activated Protein Kinases; Naphthalenes; Osmotic Pressure; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Pyridines; Rats; Rats, Sprague-Dawley; Water-Electrolyte Balance | 2000 |
AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells.
Topics: Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glomerular Mesangium; Glucose; Humans; Hyperglycemia; Imidazoles; Indoles; Maleimides; Mitogen-Activated Protein Kinases; Nuclear Proteins; p38 Mitogen-Activated Protein Kinases; Podophyllin; Podophyllotoxin; Promoter Regions, Genetic; Pyridines; RNA, Messenger; Sp1 Transcription Factor; Tetradecanoylphorbol Acetate; Tissue Distribution; Transcription Factor AP-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |